SenesTech, Inc. (SNES)
NASDAQ: SNES · Real-Time Price · USD
2.200
+0.020 (0.92%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Company Description

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control.

It offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption, as well as Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice after one to two breeding cycles following consumption.

The company also provides teleconsulting and technical advisory services. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

SenesTech, Inc.
SenesTech logo
Country United States
Founded 2004
IPO Date Dec 8, 2016
Industry Specialty Chemicals
Sector Materials
Employees 23
CEO Joel Fruendt

Contact Details

Address:
777 West Pinnacle Peak Road, Suite B104
Phoenix, Arizona 85027
United States
Phone 928 779 4143
Website senestech.com

Stock Details

Ticker Symbol SNES
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001680378
CUSIP Number 81720R208
ISIN Number US81720R5054
Employer ID 20-2079805
SIC Code 2870

Key Executives

Name Position
Joel L. Fruendt Chief Executive Officer, President and Director
Thomas C. Chesterman M.B.A. Executive Vice President, Chief Financial Officer, Treasurer and Secretary
Robert Blum Investor Relations

Latest SEC Filings

Date Type Title
Apr 22, 2025 424B5 Filing
Apr 18, 2025 PRE 14A Other preliminary proxy statements
Mar 25, 2025 D Notice of Exempt Offering of Securities
Mar 13, 2025 10-K Annual Report
Mar 12, 2025 8-K Current Report
Mar 11, 2025 8-K Current Report
Feb 14, 2025 SCHEDULE 13G/A Filing
Feb 12, 2025 SCHEDULE 13G/A Filing
Jan 10, 2025 8-K Current Report
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals